This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Diagnostic Imaging Covers Communicating Contrast Agent Risk





NORWALK, Conn., Jan. 29, 2013 /PRNewswire/ -- UBM Medica US announces that Diagnostic Imaging, a leading online publication for news and commentary of the medical imaging market, provided guidance for radiology practices to better communicate the risks of contrast agents to patients.

Although a commonly used tool in medical imaging, contrast agents aren't without their risks. In this feature article, Diagnostic Imaging spoke with industry experts about how to best provide patients with information about these radiopharmaceuticals, including:

  • Explain what the agent is and what it does in basic terminology. Use the teach-back method where patients relay the information back, demonstrating they understand, Jeffrey Kanne, MD, associate professor of thoracic imaging and quality and safety vice chair at the University of Wisconsin School of Medicine and Public Health, told Diagnostic Imaging.
  • Set up a patient education website detailing information patients need to ensure their safety and the best imaging results.

Radiologists should also make themselves available to patients to discuss contrast agents.

"We don't have a lot of patient contact as radiologists, but if patients understand that a physician trained in medical imaging is immediately available to speak with them, it can have a very beneficial impact on their experience," Kanne said.

It is also critical for imaging centers and departments to ensure providers have a full understanding of the contrast agents used. This can be done by partnering with a pharmacy to better educate the radiology professionals. The group may also employ pocket cards detailing information about each contrast agent.

About UBM Medica USAddressing today' s healthcare information needs, UBM Medica US, delivers strategic, integrated communications solutions and comprehensive reach—online, in print, and via custom programs. Improving the effectiveness of healthcare through information and education, UBM Medica US provides unbiased clinical, practical, and business information for physicians, providers, payers, and patients around the world. Through journals, magazines, websites, online communities, drug databases, digital events, and other valuable resources, UBM Medica US also delivers comprehensive communication solutions for the pharmaceutical and related industries. Websites include CancerNetwork.com, ConsultantLive.com, DiagnosticImaging.com, MusculoskeletalNetwork.com, OBGYN.net, PhysiciansPractice.com, PsychiatricTimes.com and SearchMedica.com. UBM Medica US is part of UBM Connect – which provides marketing services across a number of communities, the largest of which are healthcare, medical device design and advanced manufacturing. UBM Connect also includes UBM Studios, the global leader in interactive digital environments. UBM Connect is a UBM plc company. For more information, visit http://www.UBMMedicaUS.com



1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,080.14 +21.45 0.12%
S&P 500 2,117.69 +4.76 0.23%
NASDAQ 5,092.0850 +36.0220 0.71%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs